Afrezza FDA approval date

The FDA approved Afrezza (Technosphere Insulin) on 27 Jun 2014.

FDA approval date
27 Jun 2014

Drug identity checked against registry records

Also recorded as Technosphere Insulin

Included trials

TrialSponsorPhaseStatusPrimary completion
Afrezza® INHALE-1 Study in PediatricsNCT04974528Mannkind CorporationPhase 3Completed2024-10-03Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2014-06-27DayAfrezzaFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA022472", "applicant_as_listed_by_fda": "MANNKIND", "brand_names": ["AFREZZA"], "active_ingredients": ["INSULIN RECOMBINANT HUMAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140627", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026